UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001233 |
|---|---|
| Receipt number | R000001503 |
| Scientific Title | Phase II clinical trial of the first-line Stop-and-Go modified FOLFOX6 and bevacizmab for patients with unresectable/recurrent colorectal cancer |
| Date of disclosure of the study information | 2008/07/07 |
| Last modified on | 2012/01/12 12:37:18 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/07/07 22:22:20 | ||
| 2 | Update | 2009/02/15 22:55:14 | Last name of contact person Last name of contact person Name of person sending information |
|
| 3 | Update | 2009/02/15 22:56:02 | Recruitment status |
|
| 4 | Update | 2009/07/16 18:56:53 | UMIN ID1 |
|
| 5 | Update | 2010/07/09 13:28:40 | Name of person sending information Organization Division name Address |
|
| 6 | Update | 2010/07/09 13:29:21 | Publication of results |
|
| 7 | Update | 2012/01/12 12:33:05 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
| 8 | Update | 2012/01/12 12:37:18 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications |
